No-fault compensation for research-related injuries

Kondro, Wayne
October 2011
CMAJ: Canadian Medical Association Journal;10/18/2011, Vol. 183 Issue 15, pE1113
Academic Journal
The article discusses the recommendations of the international panel convened by the U.S. Presidential Commission for the Study of Bioethical Issues. It states that the U.S. should create a compensating system for those research-related injured people. It mentions that the panel called for more ethics training of researchers and institutional research board members. It says that the panels urged the U.S that all greater than minimal risk research to be registered and results be reported.


Related Articles

  • Clinical Trial Registries: A Practical Guide for Sponsors and Researchers of Medicinal Products.  // AMWA Journal: American Medical Writers Association Journal;2007, Vol. 22 Issue 4, p204 

    The article reviews the book "Clinical Trial Registries: A Practical Guide for Sponsors and Researchers of Medicinal Products," edited by MaryAnn Foote.

  • The Unsinkable National Institute of Education. Lambro, Donald // National Review;4/11/1986, Vol. 38 Issue 6, p40 

    Asserts that the U.S. National Institute of Education has financed thousands of studies that have done little to help, and much to harm, American education. Study of letter-writing in a bilingual school; Determination of the causes of the underfunding of teacher pensions; U.S. Office of...

  • An even safer safety net. Prentice, Ernest // Hastings Center Report;May/Jun97, Vol. 27 Issue 3, p46 

    Reports that research community has welcomed the US Food and Drug Administration's regulatory amendment to permit the waiver of consent in a limited class of emergency research activities. Similarities with the Department of Health and Human Services' emergency research consent waiver; Daunting...

  • Cheers for Bush's 1993 R&D budget cut short by problems and pessimism.  // Physics Today;Jun92, Vol. 45 Issue 6, p55 

    Discusses the issues surrounding the 1993 fiscal budget and the funding of scientific research and development (R&D). Economic recession, red ink, and limits on discretionary spending; President George Bush's $1.52 trillion budget; Efforts for a balanced budget; Growth in R&D at the expense of...

  • Funding for science: The system is broken; why not fix it? Anderson, Philip W. // Physics Today;Jun93, Vol. 46 Issue 6, p9 

    Discusses issues in government funding for science. Emphasis on big science projects by direct government funding; Lack of uniformity in levels in funding research at institutions; Less influence of scientists in the National Aeronautics and Space Administration's Space Station Freedom project;...

  • How the EC allots its research funds.  // R&D Magazine;Apr94, Vol. 36 Issue 5, p11 

    Presents a graph showing how the European Community allots its research funds from 1994 to 1998. Total budget.

  • Memorandum on Protections for Human Subjects of Classified Research. Clinton, William J. // Weekly Compilation of Presidential Documents;3/31/97, Vol. 33 Issue 13, p422 

    Presents the Memorandum on the Protection for Human Subjects of Classified Research signed by President Bill Clinton on March 27, 1997. Features of the work by the Advisory Committee on Human Radiation Experiments; Functions of the committee; Requirements that should be met by classified...

  • Statement on protections for human subjects of classified research. Clinton, Bill // Weekly Compilation of Presidential Documents;3/31/97, Vol. 33 Issue 13, p424 

    Presents the statement by President Bill Clinton on March 28, 1997 focusing on the protections for human subjects of classified research in the United States. Details of the cooperation by the government with the work of the Advisory Committee on the issue; Features of the report by the...

  • Taiwan.  // Business America;9/20/93, Vol. 114 Issue 19, p25 

    Reports on the commitment of Taiwan authorities to upgrading and expanding research and development (R&D) efforts to spur economic development. Planned increase in the R&D expenditures by public-sector laboratories; Provision of tax incentives and grants to private-sector companies; Financial...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics